Insider Activity Report: BioLife Solutions (BLFS)

wepik export 20231025170233WCv91

Casdin Partners Master Fund, a major holder of
BioLife Solutions (BLFS), recently added 927,165 shares. The buy increased the fund’s position by 12 percent, and came to a total cost of $10.37 million.

  • Special: 32,481% Growth: The SmartPhone Startup Outpacing Apple and Samsung
  • The fund was the last buyer of shares with a 58,465 share pickup back in August, for $771,400. Otherwise, company insiders, including the company’s CEO, have been regular sellers of small amounts of shares, usually in the $1,000 to $20,000 range.

    Overall, company insiders own 2 percent of shares.

    • Bill O'Reilly Interviews Wall Street Expert to Help YOU Achieve the American Dream

      "We're going to bring back the American Dream... bigger, better, bolder, richer, safer, and stronger than ever before." - President Donald Trump

      During Trump's first term, 8 million Americans became millionaires despite constant resistance from Democrats and even some Republicans in his cabinet.

      Now, with Republicans controlling both houses and the Fed cutting rates, everything is aligned for even greater growth.

      Bill O'Reilly interviews investment expert Alexander Green who reveals details on 6 stocks with the potential to soar under Trump's pro-business policies.

      Get the Details Right Here

    The cell and gene therapy tool manufacturer has lost about half its value over the past year. That poor share performance comes as the company has lost money in recent quarters, but seems extreme as revenues are down by just 3 percent.

    Today, BioLife trades at just a slight premium to their book value, and shares are going for about 5 times estimated forward earnings.
    Action to take: Shares are trading near a 52-week low, and don’t appear to have formed a bottom yet. Interested traders can likely see a better price in the coming months, and should hold off until the price starts to stabilize.

  • Special: The Crypto that Could Replace Visa?
  • For traders, the current downtrend could be a shorting opportunity. While options are limited, the January 2024 $7.50 puts, last going for about $0.40, could see mid-double-digit returns in the coming months.

     
    Disclosure: The author of this article has no position in the company mentioned here, but may trade after the next 72 hours. The author receives no compensation from any of the companies mentioned in this article.